PubMed:25345840
Annnotations
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 325-341 | HP_0002721 | denotes | immunodeficiency |
T2 | 365-381 | HP_0100726 | denotes | Kaposi's sarcoma |
T3 | 374-381 | HP_0100242 | denotes | sarcoma |
wangzhuo19_800
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-25 | CI | denotes | bevacizumab |
T2 | 223-234 | CI | denotes | bevacizumab |
T3 | 690-701 | CI | denotes | bevacizumab |
T4 | 977-988 | CI | denotes | bevacizumab |
T5 | 1613-1624 | CI | denotes | bevacizumab |
T6 | 1768-1779 | CI | denotes | bevacizumab |
T7 | 83-99 | DP | denotes | Kaposi's sarcoma |
T8 | 365-381 | DP | denotes | Kaposi's sarcoma |
T9 | 910-926 | DP | denotes | Kaposi's sarcoma |
T10 | 1844-1860 | DP | denotes | Kaposi's sarcoma |
T11 | 528-544 | DP | denotes | Kaposi's sarcoma |
Linmchun_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 977-988 | CI | denotes | bevacizumab |
T10 | 365-381 | DP | denotes | Kaposi's sarcoma |
T11 | 528-544 | DP | denotes | Kaposi's sarcoma |
T12 | 1844-1860 | DP | denotes | Kaposi's sarcoma |
T13 | 43-71 | DP | denotes | human immunodeficiency virus |
T14 | 349-352 | DP | denotes | HIV |
T15 | 501-504 | DP | denotes | HIV |
T16 | 1872-1875 | DP | denotes | HIV |
T3 | 14-25 | CI | denotes | bevacizumab |
T4 | 223-234 | CI | denotes | bevacizumab |
T5 | 690-701 | CI | denotes | bevacizumab |
T6 | 1613-1624 | CI | denotes | bevacizumab |
T7 | 1768-1779 | CI | denotes | bevacizumab |
T8 | 910-926 | DP | denotes | Kaposi's sarcoma |
T9 | 83-99 | DP | denotes | Kaposi's sarcoma |
T17 | 319-347 | DP | denotes | human immunodeficiency virus |
luoyt2021_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-25 | CI | denotes | bevacizumab |
T10 | 501-504 | DP | denotes | HIV |
T11 | 1844-1860 | DP | denotes | Kaposi's sarcoma |
T12 | 910-926 | DP | denotes | Kaposi's sarcoma |
T13 | 528-544 | DP | denotes | Kaposi's sarcoma |
T15 | 365-381 | DP | denotes | Kaposi's sarcoma |
T16 | 83-99 | DP | denotes | Kaposi's sarcoma |
T2 | 1768-1779 | CI | denotes | bevacizumab |
T3 | 1613-1624 | CI | denotes | bevacizumab |
T4 | 977-988 | CI | denotes | bevacizumab |
T5 | 690-701 | CI | denotes | bevacizumab |
T6 | 223-234 | CI | denotes | bevacizumab |
T7 | 319-347 | DP | denotes | human immunodeficiency virus |
T8 | 349-352 | DP | denotes | HIV |
T9 | 1872-1875 | DP | denotes | HIV |
T17 | 43-71 | DP | denotes | human immunodeficiency virus |